Key Events This Week
7 Sep: Stock opens at Rs.933.85, marginally down
8 Sep: Sharp gain of 2.56% to Rs.957.80 on increased volume
9 Sep: Anthem Biosciences hits new 52-week and all-time high at Rs.977
10 Sep: Slight decline amid heavy volume to Rs.941.70
11 Sep: Week closes at Rs.942.25, up 0.06% on the day
7 September 2026: Quiet Start Amid Market Weakness
Anthem Biosciences began the week at Rs.933.85, a negligible decline of 0.01% from the previous Friday’s close of Rs.933.90. Trading volume was moderate at 37,227 shares. The broader market was under pressure, with the Sensex falling 0.46% to 36,218.97. The stock’s stability on a down day for the market suggested underlying resilience.
8 September 2026: Strong Rebound on Rising Volume
The stock rebounded sharply, gaining 2.56% to close at Rs.957.80 on increased volume of 57,034 shares. This outperformance contrasted with the Sensex’s 0.21% decline to 36,144.32. The positive price action was supported by technical strength and growing investor interest, setting the stage for the week’s key milestone.
Under the radar no more! This Large Cap from Cement is emerging from turnaround with solid fundamentals intact. Discover it while it's still relatively hidden!
- - Hidden turnaround gem
- - Solid fundamentals confirmed
- - Large Cap opportunity
9 September 2026: New 52-Week and All-Time Highs Amid Market Decline
Anthem Biosciences reached a significant milestone on 9 September, touching an intraday high of Rs.977, marking both a new 52-week and all-time high. The stock closed at Rs.943.60, down 1.48% from the previous day’s close, but still demonstrating strong momentum given the broader market context. The Sensex declined 0.62% to 35,921.77, continuing its downward trend. The stock’s ability to hit record highs amid a falling market highlights its relative strength and technical bullishness.
Over the past year, Anthem Biosciences has appreciated approximately 18.05%, significantly outperforming the Sensex’s 7.39% loss over the same period. The stock trades above all key moving averages, supported by bullish MACD and Bollinger Bands indicators, signalling sustained upward momentum despite short-term volatility.
10 September 2026: Profit Taking on Heavy Volume
Following the record highs, the stock experienced a mild correction, closing at Rs.941.70, down 0.20% on a notably high volume of 253,881 shares. This volume spike suggests profit-taking activity after the recent rally. The Sensex was nearly flat, declining 0.03% to 35,912.77. Despite the dip, the stock remained well above its weekly open, maintaining a strong technical position.
11 September 2026: Week Ends with Modest Gain
Anthem Biosciences closed the week at Rs.942.25, a slight gain of 0.06% on the day, with volume of 45,699 shares. The Sensex continued its decline, falling 0.39% to 35,773.24. The stock’s weekly gain of 0.89% contrasted with the Sensex’s 1.68% loss, underscoring its outperformance in a challenging market environment.
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-09-07 | Rs.933.85 | -0.01% | 36,218.97 | -0.46% |
| 2026-09-08 | Rs.957.80 | +2.56% | 36,144.32 | -0.21% |
| 2026-09-09 | Rs.943.60 | -1.48% | 35,921.77 | -0.62% |
| 2026-09-10 | Rs.941.70 | -0.20% | 35,912.77 | -0.03% |
| 2026-09-11 | Rs.942.25 | +0.06% | 35,773.24 | -0.39% |
Key Takeaways
Anthem Biosciences demonstrated resilience and relative strength during a broadly weak market week. The stock’s ability to reach new 52-week and all-time highs on 9 September amid Sensex declines highlights strong underlying momentum and investor confidence. Technical indicators remain bullish, with the stock trading above all major moving averages and supported by positive MACD and Bollinger Bands signals.
Volume trends showed a significant spike on 10 September, indicating profit-taking after the rally, but the stock maintained its gains for the week. The Mojo Score of 64.0 and a Hold rating reflect a balanced view, acknowledging the stock’s strong price performance alongside cautious valuation and recent financial trends.
Anthem Biosciences Ltd or something better? Our SwitchER feature analyzes this mid-cap stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Conclusion
Anthem Biosciences Ltd’s performance this week underscores its capacity to outperform the broader market despite challenging conditions. The stock’s new highs and sustained technical strength reflect positive momentum, while the modest weekly gain of 0.89% contrasts favourably with the Sensex’s 1.68% decline. Investors should note the balanced Mojo Grade of Hold, which tempers enthusiasm with caution given valuation and recent financial nuances. Overall, Anthem Biosciences remains a noteworthy mid-cap stock demonstrating resilience and relative strength in a volatile market.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
